SEC Form 4 · accession 0001645627-19-000004
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Jan 18, 2019
Accepted (ET)
Jan 24, 2019 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 18, 2019 | P | 2,000 | $0.0283 | A | 26,691,897 | D | |
| Common Stock | Jan 18, 2019 | P | 2,000 | $0.0274 | A | 26,693,897 | D | |
| Common Stock | Jan 18, 2019 | P | 2,000 | $0.0284 | A | 26,695,897 | D | |
| Common Stock | Jan 18, 2019 | P | 2,000 | $0.0269 | A | 26,697,897 | D | |
| Common Stock | Jan 18, 2019 | P | 2,000 | $0.0269 | A | 26,699,897 | D |
Table II — derivative securities
No Table II lines on this filing.